HIV陽性耐性ブルキットリンパ腫におけるグローフィタマブに対する持続的反応:症例報告と議論
Bozzotto Elisa1, Magnes Theresa1, Kiem Dominik1
1Department of Internal Medicine III With Hematology, Medical Oncology, Hemostaseology, Infectiology, and Rheumatology Paracelsus Medical University University Clinic Salzburg Salzburg Austria.
EJHaem
|February 16, 2026
まとめ
グロフィタマブは,標準的な治療法を使い果たした耐火性ブルキットリンパ腫 (BL) 患者にとって有望である. 1人の患者がグロフィタマブ治療後に9ヶ月間持続した完全な寛解を達成しました.
科学分野:
- 腫瘍学 腫瘍学
- 血液学 ヘマトロジ
- 免疫療法による免疫療法です.
背景:
- 耐火性ブルキットリンパ腫 (BL) は,標準的な治療法で不良な結果を伴う重要な臨床的課題です.
- 再発性または耐火性BLの患者に対する新しい治療戦略の未満たされた需要があります.
研究 の 目的:
- 耐火性ブルキットリンパ腫の潜在的な治療法としてのグローフィタマブの有効性と安全性を評価する.
主な方法:
- 耐火性および二次性一次性BLを有する60歳のHIV陽性患者の症例報告が提示されています.
- 患者は,複数の以前の治療が失敗した後,グロフィタマブでオフレーベル治療を受けた.
主要な成果:
- glofitamabの12サイクルが投与され,耐性が良好でした.
- 患者は,画像と生検によって確認された完全な代謝寛解を達成しました.
- 治療後の寛解は9ヶ月間持続しました.
結論:
- グロフィタマブは,再発したBLの単独治療の選択肢として潜在性を示しました.
- この治療法は,従来型の細胞毒性療法が効果的でない場合,有効な代替治療法である可能性があります.
関連する概念動画
Pulmonary Tuberculosis I
1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis II
2.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Pulmonary Tuberculosis III
1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.8K


